Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Radiology | 30 | 2024 | 199 | 8.640 |
Why?
|
Education, Medical | 9 | 2023 | 243 | 2.340 |
Why?
|
Education, Medical, Undergraduate | 8 | 2023 | 178 | 2.300 |
Why?
|
Anatomy | 5 | 2017 | 20 | 2.270 |
Why?
|
Radiologists | 6 | 2022 | 45 | 1.890 |
Why?
|
Curriculum | 15 | 2022 | 567 | 1.800 |
Why?
|
Mesothelioma | 13 | 2022 | 322 | 1.790 |
Why?
|
Students, Medical | 10 | 2022 | 418 | 1.780 |
Why?
|
Tomography, X-Ray Computed | 22 | 2022 | 2649 | 1.400 |
Why?
|
Educational Measurement | 8 | 2017 | 231 | 1.400 |
Why?
|
Internship and Residency | 7 | 2022 | 1040 | 1.320 |
Why?
|
Teaching | 4 | 2014 | 147 | 1.270 |
Why?
|
Radiography | 8 | 2024 | 809 | 1.150 |
Why?
|
Pleural Neoplasms | 9 | 2022 | 197 | 1.080 |
Why?
|
Formative Feedback | 2 | 2023 | 13 | 1.010 |
Why?
|
Schools, Medical | 5 | 2023 | 134 | 0.970 |
Why?
|
Diagnostic Imaging | 5 | 2017 | 478 | 0.950 |
Why?
|
Surveys and Questionnaires | 10 | 2022 | 2607 | 0.790 |
Why?
|
Burnout, Professional | 2 | 2020 | 100 | 0.750 |
Why?
|
Peritoneal Neoplasms | 1 | 2022 | 184 | 0.720 |
Why?
|
Personnel Selection | 2 | 2017 | 60 | 0.690 |
Why?
|
Career Choice | 2 | 2017 | 148 | 0.640 |
Why?
|
Computer-Assisted Instruction | 3 | 2014 | 44 | 0.630 |
Why?
|
Interdisciplinary Communication | 1 | 2019 | 130 | 0.620 |
Why?
|
Communication | 2 | 2021 | 457 | 0.620 |
Why?
|
Workload | 1 | 2019 | 129 | 0.620 |
Why?
|
Mentoring | 1 | 2018 | 32 | 0.610 |
Why?
|
Radiology Department, Hospital | 2 | 2016 | 25 | 0.600 |
Why?
|
Humans | 72 | 2024 | 88852 | 0.580 |
Why?
|
United States | 18 | 2022 | 6931 | 0.580 |
Why?
|
Attitude of Health Personnel | 2 | 2019 | 643 | 0.550 |
Why?
|
Education, Medical, Graduate | 2 | 2017 | 390 | 0.530 |
Why?
|
Lung Neoplasms | 9 | 2022 | 2344 | 0.520 |
Why?
|
Needs Assessment | 1 | 2015 | 157 | 0.470 |
Why?
|
Biomedical Research | 1 | 2018 | 397 | 0.460 |
Why?
|
Illusions | 1 | 2013 | 12 | 0.460 |
Why?
|
Organizational Objectives | 1 | 2013 | 24 | 0.440 |
Why?
|
Models, Educational | 1 | 2013 | 48 | 0.430 |
Why?
|
Classification | 1 | 2013 | 54 | 0.430 |
Why?
|
Faculty | 1 | 2013 | 33 | 0.430 |
Why?
|
Dizziness | 1 | 2012 | 26 | 0.420 |
Why?
|
Artifacts | 2 | 2013 | 244 | 0.420 |
Why?
|
Vertigo | 1 | 2012 | 41 | 0.410 |
Why?
|
Cadaver | 1 | 2012 | 185 | 0.400 |
Why?
|
Forecasting | 1 | 2013 | 305 | 0.400 |
Why?
|
Physicians | 1 | 2019 | 689 | 0.390 |
Why?
|
Visual Perception | 1 | 2013 | 326 | 0.360 |
Why?
|
Airway Resistance | 3 | 2000 | 70 | 0.350 |
Why?
|
Ultrasonography | 4 | 2016 | 710 | 0.320 |
Why?
|
Emergency Service, Hospital | 1 | 2012 | 518 | 0.310 |
Why?
|
Male | 36 | 2019 | 42135 | 0.300 |
Why?
|
Learning | 2 | 2023 | 283 | 0.300 |
Why?
|
Female | 36 | 2022 | 45899 | 0.280 |
Why?
|
Clinical Competence | 3 | 2018 | 780 | 0.280 |
Why?
|
Models, Biological | 1 | 2013 | 1763 | 0.280 |
Why?
|
Lung | 5 | 2015 | 1257 | 0.270 |
Why?
|
Middle Aged | 29 | 2019 | 25787 | 0.250 |
Why?
|
Feedback | 2 | 2023 | 134 | 0.240 |
Why?
|
Problem-Based Learning | 1 | 2024 | 32 | 0.230 |
Why?
|
Radiographic Image Enhancement | 3 | 2015 | 463 | 0.220 |
Why?
|
Neoplasm Staging | 5 | 2022 | 1989 | 0.210 |
Why?
|
Radiation Protection | 1 | 2022 | 26 | 0.210 |
Why?
|
Adult | 20 | 2018 | 26439 | 0.210 |
Why?
|
Radiography, Thoracic | 3 | 2014 | 319 | 0.210 |
Why?
|
Aged, 80 and over | 16 | 2019 | 6758 | 0.210 |
Why?
|
Reproducibility of Results | 7 | 2019 | 2750 | 0.210 |
Why?
|
Advisory Committees | 1 | 2022 | 88 | 0.200 |
Why?
|
Data Collection | 2 | 2014 | 375 | 0.200 |
Why?
|
Ascites | 1 | 2022 | 56 | 0.200 |
Why?
|
Diaphragm | 3 | 2000 | 50 | 0.190 |
Why?
|
Phrenic Nerve | 2 | 2000 | 42 | 0.190 |
Why?
|
Aged | 24 | 2020 | 19019 | 0.190 |
Why?
|
Pilot Projects | 3 | 2019 | 865 | 0.190 |
Why?
|
Predictive Value of Tests | 2 | 2019 | 1713 | 0.190 |
Why?
|
Positron Emission Tomography Computed Tomography | 1 | 2022 | 93 | 0.190 |
Why?
|
Magnetics | 2 | 1997 | 41 | 0.180 |
Why?
|
Intubation, Intratracheal | 2 | 2000 | 147 | 0.180 |
Why?
|
Papillomavirus Vaccines | 2 | 2011 | 58 | 0.180 |
Why?
|
Virtual Reality | 1 | 2020 | 24 | 0.170 |
Why?
|
Algorithms | 4 | 2015 | 1870 | 0.170 |
Why?
|
Mediastinum | 1 | 2019 | 47 | 0.160 |
Why?
|
Artificial Intelligence | 1 | 2022 | 320 | 0.160 |
Why?
|
Image Processing, Computer-Assisted | 4 | 2011 | 1233 | 0.160 |
Why?
|
Medical Records | 1 | 2019 | 120 | 0.160 |
Why?
|
Documentation | 1 | 2019 | 103 | 0.160 |
Why?
|
Work of Breathing | 1 | 1998 | 5 | 0.160 |
Why?
|
Ventilator Weaning | 1 | 1998 | 24 | 0.150 |
Why?
|
Magnetic Resonance Imaging | 6 | 2020 | 3441 | 0.150 |
Why?
|
Angiography | 2 | 2014 | 208 | 0.150 |
Why?
|
Respiratory Function Tests | 2 | 2017 | 139 | 0.150 |
Why?
|
Psychometrics | 1 | 2019 | 329 | 0.150 |
Why?
|
Mammary Analogue Secretory Carcinoma | 1 | 2017 | 4 | 0.150 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2000 | 216 | 0.150 |
Why?
|
Streptococcus agalactiae | 1 | 1997 | 11 | 0.150 |
Why?
|
Arthritis, Infectious | 1 | 1997 | 16 | 0.150 |
Why?
|
Venous Thrombosis | 2 | 2013 | 250 | 0.150 |
Why?
|
Observer Variation | 3 | 2013 | 609 | 0.140 |
Why?
|
Streptococcal Infections | 1 | 1997 | 56 | 0.140 |
Why?
|
Arthritis, Psoriatic | 1 | 1997 | 34 | 0.140 |
Why?
|
Guidelines as Topic | 2 | 2015 | 160 | 0.140 |
Why?
|
Respiratory Physiological Phenomena | 1 | 2017 | 48 | 0.140 |
Why?
|
Point-of-Care Systems | 2 | 2016 | 148 | 0.140 |
Why?
|
Airway Obstruction | 1 | 1998 | 110 | 0.140 |
Why?
|
Pulmonary Medicine | 1 | 2017 | 46 | 0.140 |
Why?
|
Salivary Gland Neoplasms | 1 | 2017 | 67 | 0.140 |
Why?
|
Referral and Consultation | 1 | 2019 | 341 | 0.130 |
Why?
|
Cone-Beam Computed Tomography | 1 | 2016 | 63 | 0.130 |
Why?
|
Diagnosis, Differential | 3 | 2017 | 1590 | 0.130 |
Why?
|
Lung Diseases, Interstitial | 1 | 2019 | 260 | 0.130 |
Why?
|
Retrospective Studies | 10 | 2019 | 8963 | 0.130 |
Why?
|
Textbooks as Topic | 1 | 2015 | 2 | 0.130 |
Why?
|
Congresses as Topic | 1 | 2015 | 112 | 0.120 |
Why?
|
Lymph Nodes | 1 | 2019 | 548 | 0.120 |
Why?
|
Attitude | 1 | 2015 | 130 | 0.120 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2017 | 2550 | 0.120 |
Why?
|
Faculty, Medical | 1 | 2016 | 185 | 0.120 |
Why?
|
Academic Medical Centers | 1 | 2016 | 384 | 0.110 |
Why?
|
Public Opinion | 2 | 2022 | 42 | 0.110 |
Why?
|
Clinical Clerkship | 1 | 2014 | 118 | 0.100 |
Why?
|
Cerebral Cortex | 1 | 1996 | 589 | 0.100 |
Why?
|
Pulmonary Artery | 1 | 2014 | 318 | 0.100 |
Why?
|
Young Adult | 3 | 2014 | 6271 | 0.100 |
Why?
|
Societies, Medical | 1 | 2015 | 567 | 0.100 |
Why?
|
Vena Cava Filters | 1 | 2013 | 97 | 0.100 |
Why?
|
Device Removal | 1 | 2013 | 167 | 0.100 |
Why?
|
Sensitivity and Specificity | 2 | 2014 | 2013 | 0.100 |
Why?
|
Cross-Over Studies | 1 | 2012 | 389 | 0.100 |
Why?
|
Software | 2 | 2012 | 665 | 0.090 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2014 | 468 | 0.090 |
Why?
|
Gastrostomy | 2 | 2001 | 69 | 0.090 |
Why?
|
Acute Disease | 1 | 2012 | 837 | 0.090 |
Why?
|
Pulmonary Embolism | 1 | 2013 | 228 | 0.090 |
Why?
|
Antineoplastic Agents | 2 | 2019 | 2410 | 0.090 |
Why?
|
Hypertension, Pulmonary | 1 | 2014 | 351 | 0.090 |
Why?
|
Tumor Burden | 3 | 2016 | 308 | 0.090 |
Why?
|
Mothers | 1 | 2011 | 142 | 0.090 |
Why?
|
Electromyography | 3 | 2000 | 193 | 0.090 |
Why?
|
Vaccination | 1 | 2011 | 273 | 0.080 |
Why?
|
Response Evaluation Criteria in Solid Tumors | 2 | 2019 | 58 | 0.080 |
Why?
|
Practice Guidelines as Topic | 1 | 2015 | 1040 | 0.080 |
Why?
|
Hemodynamics | 3 | 2018 | 728 | 0.080 |
Why?
|
Double-Blind Method | 1 | 2012 | 1713 | 0.080 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2010 | 294 | 0.070 |
Why?
|
Positron-Emission Tomography | 2 | 2022 | 336 | 0.070 |
Why?
|
Papillomavirus Infections | 1 | 2010 | 261 | 0.070 |
Why?
|
Tattooing | 1 | 2007 | 5 | 0.070 |
Why?
|
Catheters, Indwelling | 2 | 2013 | 112 | 0.070 |
Why?
|
Body Piercing | 1 | 2007 | 6 | 0.070 |
Why?
|
Traumatology | 1 | 2007 | 30 | 0.070 |
Why?
|
Leadership | 2 | 2020 | 138 | 0.070 |
Why?
|
Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2006 | 43 | 0.070 |
Why?
|
Biomarkers | 1 | 2013 | 1753 | 0.070 |
Why?
|
Portal Vein | 1 | 2006 | 120 | 0.070 |
Why?
|
Hyperventilation | 1 | 2005 | 13 | 0.070 |
Why?
|
Brain Stem Neoplasms | 1 | 2005 | 17 | 0.070 |
Why?
|
Contrast Media | 1 | 2011 | 1090 | 0.060 |
Why?
|
Treatment Outcome | 5 | 2018 | 8178 | 0.060 |
Why?
|
Lymphoma, B-Cell | 1 | 2005 | 105 | 0.060 |
Why?
|
Liver Cirrhosis | 1 | 2006 | 254 | 0.060 |
Why?
|
Feasibility Studies | 3 | 2016 | 778 | 0.060 |
Why?
|
Adolescent | 7 | 2014 | 9201 | 0.060 |
Why?
|
Follow-Up Studies | 4 | 2013 | 3649 | 0.060 |
Why?
|
Cross-Sectional Studies | 3 | 2017 | 1698 | 0.060 |
Why?
|
Gastrointestinal Hemorrhage | 2 | 2006 | 237 | 0.050 |
Why?
|
Lung Compliance | 2 | 2000 | 15 | 0.050 |
Why?
|
Multimedia | 1 | 2022 | 9 | 0.050 |
Why?
|
Venous Pressure | 1 | 2002 | 11 | 0.050 |
Why?
|
Catheterization | 2 | 2001 | 237 | 0.050 |
Why?
|
Mentors | 1 | 2023 | 85 | 0.050 |
Why?
|
Survival Rate | 2 | 2019 | 1881 | 0.050 |
Why?
|
Educational Status | 1 | 2022 | 194 | 0.050 |
Why?
|
Respiratory Mechanics | 2 | 2000 | 102 | 0.050 |
Why?
|
Angioplasty, Balloon | 1 | 2002 | 96 | 0.050 |
Why?
|
Prosthesis Failure | 1 | 2002 | 115 | 0.050 |
Why?
|
Students | 1 | 2023 | 169 | 0.050 |
Why?
|
Perception | 1 | 2022 | 178 | 0.050 |
Why?
|
Colonic Diseases | 1 | 2001 | 61 | 0.050 |
Why?
|
Cholangiography | 1 | 2001 | 40 | 0.050 |
Why?
|
Vascular Diseases | 1 | 2002 | 118 | 0.050 |
Why?
|
Bronchography | 1 | 2000 | 11 | 0.050 |
Why?
|
Suction | 1 | 2000 | 35 | 0.050 |
Why?
|
Nuclear Family | 2 | 2011 | 92 | 0.050 |
Why?
|
Bronchoconstriction | 1 | 2000 | 56 | 0.050 |
Why?
|
Ultrasonography, Interventional | 1 | 2001 | 123 | 0.050 |
Why?
|
Blood Vessel Prosthesis | 1 | 2002 | 242 | 0.040 |
Why?
|
Wakefulness | 1 | 2000 | 135 | 0.040 |
Why?
|
Technology | 1 | 2020 | 31 | 0.040 |
Why?
|
Electric Stimulation | 1 | 2000 | 354 | 0.040 |
Why?
|
Muscle Contraction | 2 | 1997 | 284 | 0.040 |
Why?
|
Positive-Pressure Respiration | 1 | 1999 | 41 | 0.040 |
Why?
|
Renal Dialysis | 1 | 2002 | 335 | 0.040 |
Why?
|
Fellowships and Scholarships | 1 | 2020 | 120 | 0.040 |
Why?
|
Embolization, Therapeutic | 1 | 2001 | 262 | 0.040 |
Why?
|
Transducers, Pressure | 1 | 1998 | 6 | 0.040 |
Why?
|
Lung Volume Measurements | 2 | 2013 | 20 | 0.040 |
Why?
|
Tidal Volume | 1 | 1998 | 54 | 0.040 |
Why?
|
Tomography, Spiral Computed | 1 | 2018 | 77 | 0.040 |
Why?
|
Acoustics | 1 | 1998 | 51 | 0.040 |
Why?
|
Physician-Patient Relations | 1 | 2023 | 625 | 0.040 |
Why?
|
Neck Muscles | 1 | 1997 | 17 | 0.040 |
Why?
|
Mouth | 1 | 1997 | 48 | 0.040 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p18 | 1 | 2017 | 11 | 0.040 |
Why?
|
Myoepithelioma | 1 | 2017 | 11 | 0.040 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2017 | 24 | 0.040 |
Why?
|
Illinois | 1 | 2019 | 472 | 0.040 |
Why?
|
Bone and Bones | 1 | 1999 | 269 | 0.040 |
Why?
|
France | 1 | 2017 | 48 | 0.040 |
Why?
|
Parotid Gland | 1 | 2017 | 32 | 0.040 |
Why?
|
Evoked Potentials, Motor | 1 | 1996 | 18 | 0.040 |
Why?
|
Job Application | 1 | 2016 | 8 | 0.040 |
Why?
|
Neural Conduction | 1 | 1996 | 71 | 0.040 |
Why?
|
Thumb | 1 | 1996 | 22 | 0.040 |
Why?
|
Adenocarcinoma, Clear Cell | 1 | 2017 | 62 | 0.040 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 1998 | 202 | 0.040 |
Why?
|
Breast Neoplasms | 1 | 2010 | 2991 | 0.030 |
Why?
|
Time Factors | 2 | 2013 | 5313 | 0.030 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2017 | 112 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2017 | 295 | 0.030 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2017 | 133 | 0.030 |
Why?
|
School Admission Criteria | 1 | 2016 | 23 | 0.030 |
Why?
|
Gene Rearrangement | 1 | 2017 | 172 | 0.030 |
Why?
|
Translocation, Genetic | 1 | 2017 | 266 | 0.030 |
Why?
|
Pyrazoles | 1 | 2017 | 150 | 0.030 |
Why?
|
Internal Medicine | 1 | 2020 | 355 | 0.030 |
Why?
|
Respiration | 1 | 1998 | 266 | 0.030 |
Why?
|
Neovascularization, Pathologic | 1 | 2018 | 363 | 0.030 |
Why?
|
Consumer Behavior | 1 | 2015 | 30 | 0.030 |
Why?
|
Reaction Time | 1 | 1996 | 310 | 0.030 |
Why?
|
Pyridines | 1 | 2017 | 315 | 0.030 |
Why?
|
Prognosis | 2 | 2013 | 3757 | 0.030 |
Why?
|
Neural Pathways | 1 | 1996 | 318 | 0.030 |
Why?
|
Mobile Applications | 1 | 2015 | 68 | 0.030 |
Why?
|
Edema | 1 | 2014 | 70 | 0.030 |
Why?
|
Color | 1 | 2014 | 85 | 0.030 |
Why?
|
Radiation, Ionizing | 1 | 2014 | 121 | 0.030 |
Why?
|
Hot Temperature | 1 | 2014 | 208 | 0.030 |
Why?
|
Liver Transplantation | 1 | 2001 | 1175 | 0.030 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2017 | 615 | 0.030 |
Why?
|
Radiotherapy Dosage | 1 | 2014 | 470 | 0.030 |
Why?
|
Sampling Studies | 1 | 2013 | 72 | 0.030 |
Why?
|
Prospective Studies | 3 | 2013 | 4258 | 0.030 |
Why?
|
Phlebography | 1 | 2013 | 66 | 0.030 |
Why?
|
Rabbits | 1 | 2014 | 637 | 0.030 |
Why?
|
Regression Analysis | 1 | 2014 | 590 | 0.030 |
Why?
|
Evidence-Based Medicine | 1 | 2015 | 430 | 0.030 |
Why?
|
Lymphatic Metastasis | 1 | 2015 | 502 | 0.030 |
Why?
|
Immunohistochemistry | 1 | 2017 | 1796 | 0.030 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2015 | 302 | 0.030 |
Why?
|
Pemetrexed | 1 | 2012 | 76 | 0.030 |
Why?
|
Disease Progression | 1 | 2017 | 1483 | 0.030 |
Why?
|
Glutamates | 1 | 2012 | 89 | 0.030 |
Why?
|
Fractals | 1 | 2012 | 42 | 0.030 |
Why?
|
Logistic Models | 1 | 2016 | 1209 | 0.030 |
Why?
|
Fourier Analysis | 1 | 2012 | 126 | 0.030 |
Why?
|
Catheterization, Central Venous | 1 | 2013 | 115 | 0.030 |
Why?
|
Cohort Studies | 1 | 2019 | 2855 | 0.030 |
Why?
|
Reference Standards | 1 | 2012 | 144 | 0.030 |
Why?
|
ROC Curve | 1 | 2014 | 778 | 0.030 |
Why?
|
Prosthesis Design | 1 | 2013 | 295 | 0.030 |
Why?
|
Guanine | 1 | 2012 | 207 | 0.020 |
Why?
|
Deoxycytidine | 1 | 2012 | 238 | 0.020 |
Why?
|
Suburban Population | 1 | 2010 | 6 | 0.020 |
Why?
|
Michigan | 1 | 2010 | 53 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2014 | 465 | 0.020 |
Why?
|
Fluoroscopy | 2 | 2001 | 122 | 0.020 |
Why?
|
Parity | 1 | 2010 | 96 | 0.020 |
Why?
|
Cisplatin | 1 | 2012 | 617 | 0.020 |
Why?
|
Biopsy | 1 | 2014 | 1180 | 0.020 |
Why?
|
Health Surveys | 1 | 2010 | 240 | 0.020 |
Why?
|
Urban Population | 1 | 2010 | 224 | 0.020 |
Why?
|
Animals | 3 | 2015 | 27272 | 0.020 |
Why?
|
Child | 2 | 2011 | 7113 | 0.020 |
Why?
|
Mammography | 1 | 2010 | 469 | 0.020 |
Why?
|
Nursing Assessment | 1 | 2007 | 20 | 0.020 |
Why?
|
Esophageal and Gastric Varices | 1 | 2006 | 34 | 0.020 |
Why?
|
Risk Assessment | 1 | 2013 | 2286 | 0.020 |
Why?
|
Biomarkers, Tumor | 1 | 2013 | 1532 | 0.020 |
Why?
|
Pregnancy | 1 | 2010 | 3002 | 0.010 |
Why?
|
Renal Veins | 1 | 2002 | 28 | 0.010 |
Why?
|
Retreatment | 1 | 2002 | 108 | 0.010 |
Why?
|
Vena Cava, Superior | 1 | 2002 | 60 | 0.010 |
Why?
|
Angiography, Digital Subtraction | 1 | 2002 | 98 | 0.010 |
Why?
|
Intubation, Gastrointestinal | 1 | 2001 | 31 | 0.010 |
Why?
|
Constriction, Pathologic | 1 | 2002 | 217 | 0.010 |
Why?
|
Needles | 1 | 2001 | 36 | 0.010 |
Why?
|
Pulmonary Gas Exchange | 1 | 2000 | 32 | 0.010 |
Why?
|
Pulmonary Atelectasis | 1 | 2000 | 18 | 0.010 |
Why?
|
Sheep | 1 | 2000 | 250 | 0.010 |
Why?
|
Stomach | 1 | 2000 | 111 | 0.010 |
Why?
|
Equipment Design | 1 | 2000 | 415 | 0.010 |
Why?
|
Respiratory Paralysis | 1 | 1997 | 8 | 0.010 |
Why?
|
Hypertrophy | 1 | 1997 | 67 | 0.010 |
Why?
|
Electrodes | 1 | 1997 | 88 | 0.010 |
Why?
|
Pressure | 1 | 1997 | 165 | 0.010 |
Why?
|
Neck | 1 | 1997 | 103 | 0.010 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 1997 | 187 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2001 | 1835 | 0.010 |
Why?
|
Oxygen | 1 | 2000 | 742 | 0.010 |
Why?
|
Child, Preschool | 1 | 2001 | 3695 | 0.010 |
Why?
|